SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 284.16 |
| Enterprise Value ($M) | 187.04 |
| Book Value ($M) | 243.79 |
| Book Value / Share | 2.22 |
| Price / Book | 1.17 |
| NCAV ($M) | 208.92 |
| NCAV / Share | 1.90 |
| Price / NCAV | 1.36 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.62 |
| Return on Assets (ROA) | -0.55 |
| Return on Equity (ROE) | -0.64 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 7.99 |
| Current Ratio | 7.99 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 268.16 |
| Assets | 303.03 |
| Liabilities | 59.24 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | -154.07 |
| Net Income | -138.20 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -118.01 |
| Cash from Investing | -218.80 |
| Cash from Financing | 161.21 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Point72 Asset Management, L.P. | 0.10 | -98.04 | |
| 13G/A | Vanguard Group Inc | 4.90 | -3.02 | |
| 13G | Logos Global Management LP | 6.00 | 127.59 | |
| 13G/A | Bain Capital Life Sciences Fund, L.P. | 4.90 | -12.15 | |
| 13G/A | Fmr Llc | 13.10 | 62.71 | |
| 13G/A | Bb Biotech Ag | 4.90 | 10.14 | |
| 13G/A | Biotechnology Value Fund L P | 8.40 | 28.97 | |
| 13G/A | Price T Rowe Associates Inc /md/ | 1.00 | -64.03 | |
| 13G/A | Adage Capital Management, L.P. | 3.28 | ||
| 13G | BlackRock, Inc. | 7.20 | 0.00 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 556,044 | 2,169,245 | 25.63 | |
| 1,444,912 | 3,121,988 | 46.28 | |
| 402,489 | 1,120,883 | 35.91 | |
| 262,165 | 1,051,464 | 24.93 | |
| 152,163 | 1,285,762 | 11.83 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| AMPH – Amphastar Pharmaceuticals, Inc. | AMRX – Amneal Pharmaceuticals, Inc. |
| ANAB – AnaptysBio, Inc. | APLS – Apellis Pharmaceuticals, Inc. |
| ARQT – Arcutis Biotherapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io